Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Raynaud

Showing results (311-320 of 331) with videos related to

Pageof 34
Sort By:
Maturitas|July 1, 1980
Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal womenN Faure, F Labrie, G Olivier, et al.
Reproduccion|October 1, 1981
Contraception with LHRH agonists, a new physiological approachF Labrie, C Séguin, A Bélanger, et al.
Progress in Clinical and Biological Research|January 1, 1981
Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonistsF Labrie, A Bélanger, P A Kelly, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 1, 2005
Treatment of accidental intakes of plutonium and americium: guidance notesF Ménétrier, L Grappin, P Raynaud, et al.
Journal of Steroid Biochemistry|April 1, 1984
RU 16117, an orally active estriol-like weak estrogenJ P Raynaud, G Azadian-Boulanger, M M Bouton, et al.
Neuropsychiatrie De L'Enfance Et De L'Adolescence|October 27, 2020
[COVID 19: How does child psychiatry adapt in these times of adversity?]N Catheline, E Berthaut, M Bon-Saint-Côme, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1982
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Recent Progress in Hormone Research|January 1, 1971
Metabolism and protein binding of sex steroids in target organs: an approach to the mechanism of hormone actionE E Baulieu, A Alberga, I Jung, et al.
The Prostate|November 14, 2000
Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon in benign prostatic hyperplasiaF Vacherot, M Azzouz, S Gil-Diez-De-Medina, et al.
Journal of Steroid Biochemistry|July 1, 1983
New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Pageof 34

Showing results (311-320 of 331) with videos related to

Sort By:
Pageof 34
Maturitas|July 1, 1980
Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal womenN Faure, F Labrie, G Olivier, et al.
Reproduccion|October 1, 1981
Contraception with LHRH agonists, a new physiological approachF Labrie, C Séguin, A Bélanger, et al.
Progress in Clinical and Biological Research|January 1, 1981
Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonistsF Labrie, A Bélanger, P A Kelly, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 1, 2005
Treatment of accidental intakes of plutonium and americium: guidance notesF Ménétrier, L Grappin, P Raynaud, et al.
Journal of Steroid Biochemistry|April 1, 1984
RU 16117, an orally active estriol-like weak estrogenJ P Raynaud, G Azadian-Boulanger, M M Bouton, et al.
Neuropsychiatrie De L'Enfance Et De L'Adolescence|October 27, 2020
[COVID 19: How does child psychiatry adapt in these times of adversity?]N Catheline, E Berthaut, M Bon-Saint-Côme, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1982
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Recent Progress in Hormone Research|January 1, 1971
Metabolism and protein binding of sex steroids in target organs: an approach to the mechanism of hormone actionE E Baulieu, A Alberga, I Jung, et al.
The Prostate|November 14, 2000
Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon in benign prostatic hyperplasiaF Vacherot, M Azzouz, S Gil-Diez-De-Medina, et al.
Journal of Steroid Biochemistry|July 1, 1983
New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Pageof 34